CClinicalTrials.gg
CompletedNCT02237404Updated Nov 7, 2017

Economic Evaluation and Communication in Remote Monitoring of People With Pacemakers

An interventional study of Telemedicine System in Cardiovascular Disease, sponsored by University of Tromso. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-11-07.

Sponsored by University of Tromso · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to estimate the outcomes in health and cost of the follow-up of patients with pacemakers.

The initial hypothesize of this study is that remote monitoring of pacemaker will show a best relation of outcomes in costs and effectiveness than the conventional follow-up in hospital.

Read the detailed description

Cardiovascular Diseases are a major cause of global morbidity and mortality, being responsible according to the World Health Organization of the 30% of overall mortality.

Since 2001 that the first pacemaker of remote monitoring was implanted in Europe, more than 300,000 pacemaker have been implanted around the world. Despite this sharp expansion, the scientific evidence on economic evaluations of pacemaker with remote monitoring is very limited, and in our knowledge, studies including informal costs have not been conducted.

In the field of cardiology, telemedicine allows consultations with patients through monitoring systems and remote communication analyzing the ongoing heart rates of people with pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy and subcutaneous Holter. The use of remote monitoring may save time and efforts to both healthcare professionals and patients, including their informal caregivers, reducing the number of follow up visits to the hospital and reducing the associated costs with patient follow-up, which will help to improve sustainability of healthcare services.

During the 06 months of study, the patients with implant of pacemakers of both groups will be assessed of the same parameters, in 3 different moments (pre-implant and months 1, and 6 post-implantation).

Pacemakers that are going to be used in the project:

  1. Remote monitoring group: Biotronik Estella SR-T and DR-T \& Biotronik Evia SR-T and DR-T.
  2. Hospital monitoring group: St Jude Medical Endurity SR and DR \& Sorin Reply 200 SR and DR.

The study will estimate: 1) The Clinical features of the patients. 2) The effectiveness through of administration of Health-Related Quality of Life questionnaires and 3) Finally, hospital and informal costs of patients with pacemakers will be estimated by the researches.

02

Conditions studied

  • Cardiovascular Disease

Keywords

  • Follow-Up studies
  • Biological Pacemakers
  • Telemedicine
  • Efficiency
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 50 is below the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

University of Tromso is the lead sponsor of 61 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Be 18 years of age
  • Have a pacemaker implanted
  • Understand and be able to properly perform self-monitoring at home

Exclusion criteria

Exclusion Criteria:

  • Be participating in another study
  • Refuse to participate in the study
  • Have implanted a different cardiac device to the pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (actual)

Study arms

  • No intervention
    Hospital monitoring of pacemakers

    Patients have to go to the hospital to be monitorized

  • Experimental
    Remote monitoring of pacemakers

    Telemedicine System: Patients have not to go to the hospital to be monitorized

    Device: Telemedicine System

Interventions

  • DeviceTelemedicine System

    Telemedicine System is used in remote monitoring group

    Also known as: Patients are monitorized from hospital

06

What researchers measure

Primary outcomes

  1. Clinical features

    Selected variables from the medical history records: * Gender * Age * Indication for the implantation of the pacemaker. * Comorbidities * Pharmacological treatment * Vital signs * Pacemaker parameters

    Time frame: 6 months

Secondary outcomes

  1. Health-Related Quality of Life

    EuroQol-5Dimensions (EQ-5D)

    Time frame: 6 months

  2. Health-Related Quality of Life

    Minnesota Living With Heart Failure Questionnaire (MLHF)

    Time frame: 6 months

  3. Safety

    * Number of patients with Adverse Events * Type of Adverse Events diagnosed

    Time frame: 6 months

  4. Consultations and Hospitalizations unscheduled

    Number of unscheduled visits and hospitalizations

    Time frame: 6 months

  5. Direct costs

    Direct costs taken into account: * Pacemakers' costs (device implanted) * Hospitalizations' costs * Consultations' costs (hospital) * Prescribed medical transport's cost * Health personnel costs * Pharmaceutical costs

    Time frame: 6 months

  6. Indirect cost

    Maintenance of the medical consultation (hospital): * Electricity * Cleaning * Furniture * Health fungible * Equipment investment

    Time frame: 6 months

  7. Informal costs

    Costs related to the care and displacements of patients to hospital: * Displacement costs to hospital * Accommodation costs * Cost of meals * Costs for caregivers

    Time frame: 6 months

07

Study locations

1 site
  • Nordland Hospital
    Bodo, Nordland N - 8092, Norway
08

References and documents

Publications

  • Lopez-Villegas A, Catalan-Matamoros D, Peiro S, Lappegard KT, Lopez-Liria R. Cost-utility analysis of telemonitoring versus conventional hospital-based follow-up of patients with pacemakers. The NORDLAND randomized clinical trial. PLoS One. 2020 Jan 29;15(1):e0226188. doi: 10.1371/journal.pone.0226188. eCollection 2020. PubMed 31995558 ↗
  • Lopez-Liria R, Lopez-Villegas A, Enebakk T, Thunhaug H, Lappegard KT, Catalan-Matamoros D. Telemonitoring and Quality of Life in Patients after 12 Months Following a Pacemaker Implant: the Nordland Study, a Randomised Trial. Int J Environ Res Public Health. 2019 Jun 5;16(11):2001. doi: 10.3390/ijerph16112001. PubMed 31195650 ↗
  • Lopez-Villegas A, Catalan-Matamoros D, Lopez-Liria R, Enebakk T, Thunhaug H, Lappegard KT. Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial. BMC Geriatr. 2018 Sep 21;18(1):223. doi: 10.1186/s12877-018-0911-3. PubMed 30241511 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02237404
Lead sponsor
University of Tromso
Responsible party
Antonio Lopez Villegas (PhD student, University of Tromso) — Principal investigator
First posted
Sep 11, 2014
Start date
Aug 2014
Primary completion
Dec 2015
Completion
Nov 2017
Last update
Nov 7, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion